Winslow Evans & Crocker’s NeoGenomics NEO Stock Holding History

Winslow Evans & Crocker’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$11K	Hold	213	–	–	﹤0.01%	933
2020 Q3	$8K	Hold	213	–	–	﹤0.01%	796
2020 Q2	$7K	Sell	213 -1	-0.5%	-$28	﹤0.01%	810
2020 Q1	$6K	Buy	214 +124	+138%	+$3.71K	﹤0.01%	824
2019 Q4	$4K	Buy	+90	New	+$2.14K	﹤0.01%	1008
2019 Q3	–	Sell	-4,176	Closed	-$92K	–	1164
2019 Q2	$92K	Buy	+4,176	New	+$91.6K	0.03%	415

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KFO

Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Winslow Evans & Crocker's NEO Position: Q4 2020 in Review

Winslow Evans & Crocker held its NeoGenomics (NEO) position steady in Q4 2020 at 213 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

Winslow Evans & Crocker first reported a position in NEO in Q2 2019 and has held it in 6 quarters since. The position peaked at $92K in Q2 2019. 340 funds tracked by Wall St. Rank hold NEO as of Q4 2020.

Winslow Evans & Crocker held 213 shares of NeoGenomics worth $11K as of Q4 2020.
Winslow Evans & Crocker left its NeoGenomics share count unchanged in Q4 2020.
NeoGenomics made up ﹤0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #933 holding.
Winslow Evans & Crocker first reported a position in NeoGenomics in Q2 2019 and has held it in 6 quarters since.
Winslow Evans & Crocker's NeoGenomics position peaked at $92K in Q2 2019.
340 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.